ER and HER2 expression are positively correlated in HER2 non-overexpressing breast cancer.
about
Molecular and Genetic Predictors of Breast-to-Brain Metastasis: Review and Case PresentationInverse regulation of EGFR/HER1 and HER2-4 in normal and malignant human breast tissue.The HER2-encoded miR-4728-3p regulates ESR1 through a non-canonical internal seed interactionA systematic analysis of miRNA-mRNA paired variations reveals widespread miRNA misregulation in breast cancer.KIF2A silencing inhibits the proliferation and migration of breast cancer cells and correlates with unfavorable prognosis in breast cancer.Serum thymidine kinase 1 levels predict cancer-free survival following neoadjuvant, surgical and adjuvant treatment of patients with locally advanced breast cancerHER2 and ESR1 mRNA expression levels and response to neoadjuvant trastuzumab plus chemotherapy in patients with primary breast cancerHER2 induced EMT and tumorigenicity in breast epithelial progenitor cells is inhibited by coexpression of EGFR.Cancer and the metastatic substrate.Subtype classification for prediction of prognosis of breast cancer from a biomarker panel: correlations and indicationsHuman epidermal growth factor receptor 2 (HER2)-positive and hormone receptor-positive breast cancer: new insights into molecular interactions and clinical implications.Predictive molecular markers in metastases to the central nervous system: recent advances and future avenues.HR+HER2- breast cancers with growth factor receptor-mediated EMT have a poor prognosis and lapatinib downregulates EMT in MCF-7 cells.Whole transcriptome analysis of the ERα synthetic fragment P295-T311 (ERα17p) identifies specific ERα-isoform (ERα, ERα36)-dependent and -independent actions in breast cancer cells.A meta-analysis on concordance between immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) to detect HER2 gene overexpression in breast cancer.Machine learning approaches to decipher hormone and HER2 receptor status phenotypes in breast cancer.Comparative study of Her-2, p53, Ki-67 expression and clinicopathological characteristics of breast cancer in a cohort of northern China female patients.An international study comparing conventional versus mRNA level testing (TargetPrint) for ER, PR, and HER2 status of breast cancer.Regulation of CNKSR2 protein stability by the HECT E3 ubiquitin ligase Smurf2, and its role in breast cancer progression.RNA-based determination of ESR1 and HER2 expression and response to neoadjuvant chemotherapy.Immunohistochemistry and alternative FISH testing in breast cancer with HER2 equivocal amplification.
P2860
Q26800626-849FC99D-ABE6-4EF9-8B94-8BF28D9830F2Q31134061-19799299-AB69-430D-B1B5-5B478DDED155Q33609935-ED24E126-E948-46D0-A1E3-F41D4509D3CDQ33737607-F80CDDC8-8DD7-40E1-A6A8-C27907627A45Q33825733-2C85476E-75DD-483C-86E9-46A736824B9CQ34411112-6EA7B582-0739-437B-A083-C711E8AD278DQ36903047-AE0B16F1-158C-488B-BCAF-9EB78413B94DQ37169043-9470F097-6AA8-44BF-AA50-C3E1C9C62084Q37573461-50CE8103-1C50-491E-8B9D-98F9F8239E85Q37607746-C8C7C4C9-E3E8-4438-A549-03DDBC4F87CEQ38125970-41CA5DA2-6676-4355-9C16-14FCA181B9F5Q38257364-939D9409-508B-4387-939C-234590D6378FQ38710164-A26107B7-CFBF-4574-AC2A-7DD3076B5CECQ39183133-83C7896B-8B3D-4E5B-B051-092A9CC960F1Q45782977-889C4610-6512-47C6-A0A6-F76A92F1B983Q45944833-E2F72A56-5C66-46D7-B544-D7CDB9740988Q47894073-0A51CDDD-BB65-4B37-838B-076A59AF51D6Q51663878-BF5F38D9-04A5-45EA-8D77-A19E7EADAC57Q52657648-0A6B182E-184B-4CA9-8691-3637094DBA57Q52886164-B5ACC0B0-9CF4-4745-BE7C-2407EED7DB18Q55364226-1EC795CA-B3DA-461A-A561-C9F432B11C0F
P2860
ER and HER2 expression are positively correlated in HER2 non-overexpressing breast cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
ER and HER2 expression are pos ...... -overexpressing breast cancer.
@ast
ER and HER2 expression are pos ...... -overexpressing breast cancer.
@en
type
label
ER and HER2 expression are pos ...... -overexpressing breast cancer.
@ast
ER and HER2 expression are pos ...... -overexpressing breast cancer.
@en
prefLabel
ER and HER2 expression are pos ...... -overexpressing breast cancer.
@ast
ER and HER2 expression are pos ...... -overexpressing breast cancer.
@en
P2093
P2860
P50
P356
P1476
ER and HER2 expression are pos ...... -overexpressing breast cancer.
@en
P2093
Georges Sumo
Isabel Pinhel
Jack Cuzick
Janine Salter
Judith M Bliss
Margaret Hills
NCRI Adjuvant Breast Cancer Trial Management Group
Roger A'Hern
Suzanne Drury
P2860
P2888
P356
10.1186/BCR3145
P5530
P577
2012-03-14T00:00:00Z
P5875
P6179
1023808052